Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine vs Lidocaine for Supplemental Infiltration in Irreversible Pulpitis
NCT07869394Phase 4Completed
- Sponsor
- Rehman Medical Institute
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
A Phase 4 trial of articaine in irreversible pulpitis, sponsored by Rehman Medical Institute. Started Mar 2026; status: completed.
02
Drugs
articaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07869394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869394.